在慢性疹中Omalizumab的现实有效性:一项临床观察研究
Fan Zhang1, Jiashun Liao2, Yuan Qian2
1Department of Dermatology and Venereology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
International archives of allergy and immunology
|March 21, 2024
概括
在中国患者中,奥马利祖马布通过控制症状和清除皮肤病变,有效地治疗慢性疹 (CU). 治疗持续时间和剂量可能需要根据同时存在的过敏状况进行调整.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 临床药理学 临床药理学
背景情况:
- 慢性疹 (CU) 是一个重大的临床挑战.
- 奥马利祖马布是一种新兴的治疗选择,用于耐火性CU.
研究的目的:
- 评估奥马利祖马布在治疗慢性疹症中的临床有效性和安全性.
- 评估接受奥马利祖马布的CU患者的症状控制和病变回归.
主要方法:
- 分析了一组96名用奥马利祖马布治疗的CU患者.
- 数据收集时间为2023年3月至9月.
- 使用7天疹活动评分和疹控制测试来测量有效性.
主要成果:
- 在42名患者中观察到完全的症状缓解,并对其进行了超过3个月的随访.
- 在随访队列中没有记录症状的复发.
- 在患有并发症和没有并发症的患者,以及患有/没有过敏性鼻炎的患者之间,在治疗持续时间和剂量方面发现了显著的差异 (p < 0.01).
结论:
- 奥马利祖马布有效治疗中国患者的慢性疹,提供症状控制和皮肤病变回归.
- 通常需要12周的治疗期来评估奥马利祖马布的治疗疗效.
- 伴随性过敏状况需要仔细考虑调整奥马利祖马布剂量.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
288
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288
Antiasthma Drugs: Leukotriene Modifiers
291
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
291
Dose-Response Relationship: Potency and Efficacy
4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K


